Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture;Anti-NMDA-rezeptor-enzephalitis ein interdisziplinäres krankheitsbild

Nervenarzt

Volumn 81, Issue 4, 2010, Pages 396-408

  Pruss H ^a   Dalmau, J ^b   Arolt, V ^c   Wandinger, K P ^d,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Institute of Experimental Immunology   (Germany)

Author keywords

Anti NMDA receptor encephalitis; Clinical picture; Diagnostic procedures; Interdisciplinary treatment; Prognosis

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN; RITUXIMAB; STEROID;

ANTIBODY SPECIFICITY; ARTIFICIAL VENTILATION; CANCER SURGERY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; ENCEPHALITIS; GROUPS BY AGE; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE; NMDA RECEPTOR ANTIBODY ENCEPHALITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TERATOMA; PATIENT CARE; PHYSICIAN; PLASMAPHERESIS; PROGNOSIS; REVIEW;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; COOPERATIVE BEHAVIOR; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSIVE AGENTS; INTERDISCIPLINARY COMMUNICATION; LIMBIC ENCEPHALITIS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; PARANEOPLASTIC SYNDROMES; PATIENT CARE TEAM; PLASMAPHERESIS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; YOUNG ADULT;

EID: 77953610372     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2908-9     Document Type: Review

References (41)

1. Alamowitch S, Graus F, Uchuya M et al (1997) Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 120:923-928
2. Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764-1777
3. Arolt V, Ohrmann P, Rothermundt M (2006) Schizophrenie und verwandte Störungen - Neurobiologie. In: Förstl H, Hautzinger M, Roth G (Hrsg) Neurobiologie psychischer Störungen. Springer, Heidelberg, S 345-386
4. Bakheit AM, Kennedy PG, Behan PO (1990) Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry 53:1084-1088
5. Bataller L, Kleopa KA, Wu GF et al (2007) Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 78:381-385
6. Bien CG, Schulze-Bonhage A, Deckert M et al (2000) Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy. Neurology 55:1823-1828
7. Brierley JB, Corsellis JAN, Hierons R et al (1960) Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain 83:357-368
8. Buckley C, Oger J, Clover L et al (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50:73-78
9. Corsellis JA, Goldberg GJ, Norton AR (1968) " Limbic encephalitis" and its association with carcinoma. Brain 91:481-496
10. Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365-384
11. Dalmau J, Tuzun E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-D- aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25-36 (Pubitemid 46214241)
12. Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091-1098
13. DeGiorgio LA, Konstantinov KN, Lee SC et al (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1175-1176
14. Florance NR, Davis RL, Lam C et al (2009) Anti-NMDA receptor encephalitis in children and adolescents. Ann Neurol 66:11-18
15. Gultekin SH, Rosenfeld MR, Voltz R et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123:1481-1494
16. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10(1):40-68
17. Iizuka T, Sakai F, Ide T et al (2008) Anti-NMDAR encephalitis in Japan: long-term outcome without tumor removal. Neurology 70(7):504-511
18. Iizuka T, Sakai F (2008) Anti-NMDA receptor encephalitis - clinical manifestations and pathophysiology. Brain Nerve 60(9):1047-1060
19. Ishiura H, Matsuda S, Higashihara M et al (2008) Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 71:1921-1923
20. Kleinig TJ, Thompson PD, Matar W et al (2008) The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 23:1256-1261
21. Koide R, Shimizu T, Koike K et al (2007) EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol 81:71-74
22. Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65(4):424-434
23. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8:413-426
24. Lawn ND, Westmoreland BF, Kiely MJ et al (2003) Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78:1363-1368
25. Manahan-Vaughan D, Haebler D von, Winter C et al (2008) A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 18:125-134
26. Newsom-Davis J (2004) Lambert-Eaton myasthenic syndrome. Rev Neurol 160:177-180
27. Niehusmann P, Dalmau D, Rudlowski D et al (2009) Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66(4):458-464
28. Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33(6):523-533
29. Pozo-Rosich P, Clover L, Saiz A et al (2003) Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 54:530-533
30. Sansing LH, Tüzün E, Ko MW et al (2007) A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 3:291-296
31. Shimazaki H, Ando Y, Nakano I et al (2007) Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry 78:324-325
32. Stone JM, Morrison PD, Pilowsky LS (2007) Glutamate and dopamine dysregulation in schizophrenia. J Psychopharmacol 21(4):440-452
33. Thieben MJ, Lennon VA, Boeve BF et al (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62:1177-1182
34. Tüzün E, Dalmau J (2007) Limbic encephalitis and variants: Classification, diagnosis and treatment. Neurologist 13:261-271 (Pubitemid 47396312)
35. Tyler KL (2004) Update on herpes simplex encephalitis. Rev Neurol Dis 1:169-178
36. Vincent A, Buckley C, Schott JM et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701-712
37. Vincent A, McConville J, Farrugia ME et al (2003) Antibodies in myasthenia gravis and related disorders. Ann N Y Acad Sci 998:324-335
38. Voltz R, Gultekin SH, Rosenfeld MR et al (1999) A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340:1788-1795
39. Wandinger KP, Dalmau J, Borowski K et al (2009) Recombinant immunofluorescence assay for the detection of anti-glutamate receptor (type NMDA) antibodies in the differential diagnosis of autoimmune encephalopathies. In: Conrad K et al (Hrsg) From pathogenesis to therapy of autoimmune diseases. Autoantigens, autoantibodies, autoimmunity. Pabst Sci Publishers 6:434-435
40. Whitley RJ (2006) Herpes simplex encephalitis: adolescents and adults. Antiviral Res 71:141-148
41. Zerr DM (2006) Human herpesvirus 6: a clinical update. Herpes 13:20-24